Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase (2) Clinical Trial Studying the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome

NCT04751136 is registered in ClinicalTrials.gov with Mansoura University Children Hospital as lead sponsor.

NCT NCT04751136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04751136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase (2) Clinical Trial Studying the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome
Lead sponsor
Mansoura University Children Hospital
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2016
Completion date
August 30, 2019
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome